Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
Publication
, Other
Patel, R; Saab, K; Luo, L; Ma, Y; Osman, RA; Williams, NT; Everitt, J; Zelazowski, MJ; Castro, P; Decker, WK; Hudson, WH; Myers, JN ...
October 1, 2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, R., Saab, K., Luo, L., Ma, Y., Osman, R. A., Williams, N. T., … Kirsch, D. G. (2025). Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. https://doi.org/10.1158/1078-0432.30254933
Patel, Rutulkumar, Kalil Saab, Lixia Luo, Yan Ma, Rashid Abdullah Osman, Nerissa T. Williams, Jeffrey Everitt, et al. “Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma,” October 1, 2025. https://doi.org/10.1158/1078-0432.30254933.
Patel R, Saab K, Luo L, Ma Y, Osman RA, Williams NT, et al. Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. 2025.
Patel, Rutulkumar, et al. Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. 1 Oct. 2025. Crossref, doi:10.1158/1078-0432.30254933.
Patel R, Saab K, Luo L, Ma Y, Osman RA, Williams NT, Everitt J, Zelazowski MJ, Castro P, Decker WK, Hudson WH, Myers JN, Sandulache VC, Frederick MJ, Mowery YM, Kirsch DG. Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. 2025.